Typicality: | 0.250 |
Saliency: | 0.000 |
in patients with stage ii | 3 | other |
aid → predict → disease-free and overall survival | 3 |
negative | neutral | positive |
0.012 | 0.770 | 0.218 |
Raw frequency | 3 |
Normalized frequency | 0.000 |
Modifier score | 0.500 |
Perplexity | 122.536 |